Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Pharmacist-Led Care Leads to Better Outcomes in ASCVD | ASHP Midyear
Drug Topics December 9, 2024
Patients with ASCVD experienced a more significant reduction in LDL-C.
Patients with atherosclerotic cardiovascular disease (ASCVD) experienced a significant reduction in low-density lipoprotein (LDL) cholesterol when their care was managed by an ambulatory cardiology pharmacist. This is according to research results presented at the American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition, held December 8 to 12 in New Orleans, Louisiana.1
In a retrospective, single-center cohort review, researchers evaluated the reduction in average LDL cholesterol in patients with ASCVD based on whether patients were managed via usual care or by an ambulatory cardiology pharmacist.
A total of 53 patients were included in the study. The primary outcome was average LDL reduction; the key secondary outcomes included the...
Today's Sponsors
Today's Sponsor